Pan-European radiotherapy group MedEuropa has entered the French market by acquiring a radiotherapy clinic on the site of an Elsan hospital. HBI speaks to CEO Ralph Hefti.
HBI talks to the CEO of Elsan, France's second-largest private hospital group and the largest private equity-owned one by revenue outside of the US, as it approaches its sixth - and possibly final - year of ownership by CVC. In this wide-ranging interview, Chiche discusses the group's strategy, the French market and exclusively reveals its latest acquisition.
Canada's largest single-profession pension fund has become the lead investor in the KRY's €140m Series C funding round. HBI speculates on the investment, the valuation and future plans of Europe's largest digital health player.
Three Spanish-headquartered companies are set to combine following their acquisition by mid-market investment bank and asset management firm Alantra Private Equity.
Christmas is fast approaching, and hot on its heels, the New Year sales. Here at HBI, we like a high street deal as much as the next man, but it’s what’s in the healthcare services pipeline in 2020 that’s caught our eye today.
Europe's largest lab groups could both sell in 2020, with Apax appointing Rothschild to explore a sale of Unilabs while Synlab's majority owner Cinven is also weighing up an exit. The sale values including debt could potentially reach €10bn combined.
US-based asset management group Rohatyn Group (TRH) has invested in pan-European radiotherapy provider Amethyst, and will share control with the groups two founders.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.
